Therapeutic Advances in Urology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q1 | 77.6% | 1.111 | Q1 | 86.5% |
| 2024 | 3.5 | Q1 | 83.6% | 0.941 | Q1 | 82.6% |
| 2023 | 2.6 | Q2 | 69.0% | 0.683 | Q2 | 74.9% |
| 2022 | 2.0 | Q3 | 48.8% | 0.698 | Q2 | 76.7% |
| 2021 | 3.1 | Q2 | 70.6% | 0.669 | Q2 | 76.1% |
| 2020 | — | — | 1.115 | Q1 | 87.6% | |
| 2019 | — | — | 0.651 | Q2 | 74.9% | |
| 2018 | — | — | 1.011 | Q1 | 84.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1756-2880
ISSN
1756-2872
country
UScoverage
2009-2026